https://commons.ru.ac.za/vital/access/manager/Index ${session.getAttribute("locale")} 5 The use of experimental design in the development of an HPLC–ECD method for the analysis of captopril https://commons.ru.ac.za/vital/access/manager/Repository/vital:44163 Tue 14 May 2024 11:59:47 SAST ]]> Evaluation of rate of swelling and erosion of verapamil (VRP) sustained-release matrix tablets https://commons.ru.ac.za/vital/access/manager/Repository/vital:44192 Tue 14 May 2024 11:05:45 SAST ]]> The effects of buffer molarity, agitation rate and mesh size on verapamil release from modified release mini-tablets using USP Apparatus 3 https://commons.ru.ac.za/vital/access/manager/Repository/vital:6386 Tue 14 May 2024 11:05:12 SAST ]]> The evaluation of Eudragit microcapsules manufactured by solvent evaporation using USP Apparatus 1 https://commons.ru.ac.za/vital/access/manager/Repository/vital:6389 Tue 14 May 2024 11:04:45 SAST ]]> Swelling, erosion and drug release characteristics of salbutamol sulfate from hydroxypropyl methylcellulose-based matrix tablets https://commons.ru.ac.za/vital/access/manager/Repository/vital:44177 Tue 14 May 2024 11:04:25 SAST ]]> Drug transport mechanisms from carbopol/eudragit verapamil sustained-release tablets https://commons.ru.ac.za/vital/access/manager/Repository/vital:44273 Tue 14 May 2024 11:03:40 SAST ]]> The use of response surface methodology in the evaluation of captopril microparticles manufactured using an oil in oil solvent evaporation technique https://commons.ru.ac.za/vital/access/manager/Repository/vital:44191 Tue 14 May 2024 11:03:22 SAST ]]> In vitro dissolution kinetics of Captopril from microspheres manufactured by solvent evaporation https://commons.ru.ac.za/vital/access/manager/Repository/vital:6390 Tue 14 May 2024 11:02:59 SAST ]]> The impact of manufacturing variables on in vitro release of clobetasol 17-propionate from pilot scale cream formulations https://commons.ru.ac.za/vital/access/manager/Repository/vital:44077 Tue 14 May 2024 11:02:38 SAST ]]> The use of experimental design for the development of a capillary zone electrophoresis method for the quantitation of captopril https://commons.ru.ac.za/vital/access/manager/Repository/vital:44073 Tue 14 May 2024 10:59:49 SAST ]]> The use of experimental design for the development and validation of an HPLC-ECD method for the quantitation of efavirenz https://commons.ru.ac.za/vital/access/manager/Repository/vital:44006 Tue 14 May 2024 10:59:25 SAST ]]> Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: Method scaling versus re-validation. https://commons.ru.ac.za/vital/access/manager/Repository/vital:43984 Tue 14 May 2024 10:58:54 SAST ]]> Design, evaluation and optimization of taste masked clarithromycin powder https://commons.ru.ac.za/vital/access/manager/Repository/vital:44001 Tue 14 May 2024 10:58:36 SAST ]]> An artificial neural network approach to predict the effects of formulation and process variables on prednisone release from a multipartite system https://commons.ru.ac.za/vital/access/manager/Repository/vital:43933 Tue 14 May 2024 10:58:09 SAST ]]> The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds https://commons.ru.ac.za/vital/access/manager/Repository/vital:43981 Tue 14 May 2024 10:57:46 SAST ]]> Formulation optimization of smart thermosetting lamotrigine loaded hydrogels using response surface methodology, box benhken design and artificial neural networks https://commons.ru.ac.za/vital/access/manager/Repository/vital:43936 Tue 14 May 2024 10:57:23 SAST ]]> Formulation and Characterisation of a Combination Captopril and Hydrochlorothiazide Microparticulate Dosage Form https://commons.ru.ac.za/vital/access/manager/Repository/vital:43926 75% for both hydrochlorothiazide and captopril. The microparticulate technology is able to offer potential resolution to the half-life mediated dosing frequency of captopril as sustained release of the molecule was observed over a 12-h period. The release of hydrochlorothiazide of >80% suggests an improvement in solubility limited dissolution.]]> Tue 14 May 2024 10:56:57 SAST ]]> Design, Optimization, Manufacture and Characterization of Efavirenz-Loaded Flaxseed Oil Nanoemulsions https://commons.ru.ac.za/vital/access/manager/Repository/vital:43919 Tue 14 May 2024 10:55:07 SAST ]]> Muco-adhesive clarithromycin-loaded nanostructured lipid carriers for ocular delivery: Formulation, characterization, cytotoxicity and stability https://commons.ru.ac.za/vital/access/manager/Repository/vital:43916 Tue 14 May 2024 10:54:28 SAST ]]>